Press Releases on May 26, 2020 - EIN Presswire - Press Release Distribution Service

Published on May 26, 2020 - 10:50 GMT

Zynerba Pharmaceuticals Announces Presentation of Phase 2 BELIEVE Safety, Efficacy and Quality of Life Data in Developmental and ...

DEVON, Pa., May 26, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters on …

Distribution channels:

Published on May 26, 2020 - 10:50 GMT

IMS Announces New Industry Partnership with Conversational AI Platform Provider, SmarTek21

Boston, MA and Waterloo, ON, Canada, May 26, 2020 (GLOBE NEWSWIRE) -- IMS (Insurance & Mobility Solutions), a subsidiary of Trak Global Group (TGG) and one of the world’s top three providers of connected car data solutions to insurers, mobility …

Distribution channels: Companies, Media, Advertising & PR ...

Published on May 26, 2020 - 10:47 GMT

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Breast Neoplasms;Stomach Neoplasms, Date of ...

Breast cancer Metastatic breast cancer Zercepac is indicated for the treatment of adult patients with HER2 positive metastatic breast cancer (MBC): as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 26, 2020 - 10:47 GMT

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Breast Neoplasms;Stomach Neoplasms, Date of ...

Breast cancer Metastatic breast cancer Zercepac is indicated for the treatment of adult patients with HER2 positive metastatic breast cancer (MBC): as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 26, 2020 - 10:46 GMT

1Life Healthcare (One Medical) Announces Proposed Private Offering of $250 Million of Convertible Senior Notes Due 2025

SAN FRANCISCO, May 26, 2020 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that it intends to offer, subject to market conditions and other factors, $250 million aggregate principal amount of convertible senior …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 26, 2020 - 10:45 GMT

Lands' End Announces First Quarter Fiscal 2020 Earnings Conference Call

DODGEVILLE, Wis., May 26, 2020 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Tuesday, June 2, 2020, to discuss its first quarter fiscal 2020 financial results. A news release containing …

Distribution channels: Culture, Society & Lifestyle, Textiles & Fabric Industry ...

Published on May 26, 2020 - 10:44 GMT

Global Yacht Charter Market to Reach $25.2 Billion by 2026: AMR

Portland, OR, May 26, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global yacht charter market generated $15.2 billion in 2018 and is estimated to reach $25.2 billion by 2026, registering a CAGR of 6.3% from …

Distribution channels: Banking, Finance & Investment Industry, Book Publishing Industry ...

Published on May 26, 2020 - 10:44 GMT

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Hemorrhagic Fever, ...

Zabdeno is a vaccine to protect adults and children aged one year and older against Ebola virus disease caused by Zaire ebolavirus. It is used with another Ebola vaccine called Mvabea as part of a vaccine regimen. Zabdeno contains a virus known as …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 26, 2020 - 10:44 GMT

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Hemorrhagic Fever, ...

Zabdeno is a vaccine to protect adults and children aged one year and older against Ebola virus disease caused by Zaire ebolavirus. It is used with another Ebola vaccine called Mvabea as part of a vaccine regimen. Zabdeno contains a virus known as …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 26, 2020 - 10:37 GMT

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Cancer;Carcinoma, Non-Small-Cell Lung, Date of ...

The most common side effects with Rozlytrek (which may affect more than 1 in 5 people) are tiredness, constipation, dysgeusia (taste disturbances), oedema (swelling with fluid retention), dizziness, diarrhoea, nausea (feeling sick), dysaesthesia ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 26, 2020 - 10:37 GMT

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Cancer;Carcinoma, Non-Small-Cell Lung, Date of ...

The most common side effects with Rozlytrek (which may affect more than 1 in 5 people) are tiredness, constipation, dysgeusia (taste disturbances), oedema (swelling with fluid retention), dizziness, diarrhoea, nausea (feeling sick), dysaesthesia ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 26, 2020 - 10:37 GMT

Small Caliber Ammunition Market Size to Reach USD 8.86 Billion by 2026; Rising Adoption of Smokeless Bullets to Aid Growth, Says ...

Pune, May 26, 2020 (GLOBE NEWSWIRE) -- The global small caliber ammunition market is anticipated to gain impetus from the ever-increasing usage of zinc and copper alloys for covering bullets. It not only enhances performance, but also provides jacket. …

Distribution channels: